NAT2 variants and toxicity related to anti-tuberculosis agents: a systematic review and meta-analysis

BACKGROUND: Tuberculosis (TB) patients receiving anti-tuberculosis treatment may experience serious adverse drug reactions (ADRs) such as hepatotoxicity. Variants of the N-acetyltransferase 2 (NAT2) gene may increase the risk of experiencing such toxicity events. OBJECTIVE: To provide a comprehensiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Richardson, M., Kirkham, J., Dwan, K., Sloan, D. J., Davies, G., Jorgensen, A. L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Union Against Tuberculosis and Lung Disease 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6421944/
https://www.ncbi.nlm.nih.gov/pubmed/30871660
http://dx.doi.org/10.5588/ijtld.18.0324

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6421944/
https://www.ncbi.nlm.nih.gov/pubmed/30871660
http://dx.doi.org/10.5588/ijtld.18.0324

Ejemplares similares